Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study.
Authors: Martano Manuela, Corteggio Annunziata, Restucci Brunella, De Biase Maria Ester, Borzacchiello Giuseppe, Maiolino Paola
Journal: BMC veterinary research
Summary
# Editorial Summary Equine sarcoids represent a persistent clinical challenge, with bovine papillomavirus (BPV-1 and BPV-2) implicated as the causative agent, yet the precise mechanisms driving tumour development remain unclear. Martano and colleagues examined extracellular matrix (ECM) composition and remodelling activity in 25 naturally occurring equine sarcoids compared to five normal skin samples, using immunohistochemistry and molecular analysis to quantify collagen types I and III, vimentin, alpha-smooth muscle actin, and the matrix metalloproteinases (MMPs-2, -9, -14) alongside their inhibitor TIMP-2. The sarcoid tissue demonstrated significantly altered ECM architecture with abnormal collagen deposition patterns, elevated MMP expression (particularly MMP-2 and MMP-9), and reduced TIMP-2 levels, indicative of pathological matrix remodelling that favours ongoing tissue breakdown and fibroblastic proliferation. These findings support the hypothesis that BPV infection, potentially triggered by immunosuppression or mechanical injury, initiates a dysregulated wound-healing response characterised by unchecked matrix degradation and aberrant fibroblastic activity. Understanding this ECM remodelling profile may guide future therapeutic strategies targeting MMP activity or collagen stabilisation, offering farriers, veterinarians and physiotherapists mechanistic insight into why sarcoids persist despite conventional treatment and informing decisions around wound management in sarcoid-prone individuals.
Read the full abstract on PubMed
Practical Takeaways
- •Early intervention and prevention of mechanical injury to skin may reduce sarcoid development risk in predisposed horses, as wound healing dysregulation appears central to pathogenesis
- •Understanding the role of chronic inflammation and matrix remodeling in sarcoids could inform future treatment strategies targeting MMPs or collagen dysregulation
- •Maintain good immune status and wound care practices, as immunosuppression combined with BPV infection appears to promote sarcoid transformation
Key Findings
- •Equine sarcoids show altered extracellular matrix composition with abnormal collagen I and III expression patterns compared to normal skin
- •Matrix metalloproteinases (MMP-2, MMP-9, MMP-14) and their tissue inhibitors (TIMP-2) are differentially expressed in sarcoid tissue, indicating active matrix remodeling
- •Vimentin and alpha-smooth muscle actin expression suggests fibroblastic differentiation and myofibroblast involvement in sarcoid pathogenesis
- •BPV-1/BPV-2 infection may trigger pathologic wound healing responses that transform into sarcoid tumors, particularly in genetically predisposed horses